RJT
IONS icon

Raymond James Trust’s Ionis Pharmaceuticals IONS Stock Holding History

Raymond James Trust’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-4,187
Closed -$253K – 887
2019
Q4 		$253K Sell
4,187
-1,150
-22% -$68.5K 0.01% 774
2019
Q3 		$320K Buy
5,337
+866
+19% +$56.4K 0.02% 632
2019
Q2 		$287K Sell
4,471
-23
-0.5% -$1.63K 0.02% 643
2019
Q1 		$365K Sell
4,494
-899
-17% -$58K 0.02% 524
2018
Q4 		$292K Sell
5,393
-448
-8% -$22.8K 0.02% 564
2018
Q3 		$302K Buy
5,841
+22
+0.4% +$1.03K 0.02% 629
2018
Q2 		$243K Sell
5,819
-134
-2% -$5.94K 0.01% 698
2018
Q1 		$263K Buy
5,953
+145
+2% +$7.37K 0.02% 572
2017
Q4 		$292K Buy
5,808
+136
+2% +$7.46K 0.02% 542
2017
Q3 		$287K Buy
5,672
+119
+2% +$6.23K 0.02% 551
2017
Q2 		$282K Sell
5,553
-152
-3% -$7.08K 0.02% 551
2017
Q1 		$229K Buy
5,705
+159
+3% +$7.14K 0.02% 595
2016
Q4 		$265K Buy
+5,546
New +$219K 0.02% 521
2016
Q1 		– Sell
-3,920
Closed -$243K – 698
2015
Q4 		$243K Buy
+3,920
New +$212K 0.02% 538
2015
Q3 		– Sell
-3,872
Closed -$223K – 636
2015
Q2 		$223K Buy
3,872
+132
+4% +$8.39K 0.02% 542
2015
Q1 		$238K Sell
3,740
-1,725
-32% -$117K 0.03% 521
2014
Q4 		$337K Buy
5,465
+203
+4% +$10K 0.04% 410
2014
Q3 		$204K Buy
+5,262
New +$186K 0.02% 548
2014
Q2 		– Sell
-5,898
Closed -$255K – 622
2014
Q1 		$255K Buy
+5,898
New +$286K 0.03% 450

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Raymond James Trust's IONS Position: Q1 2020 in Review

Raymond James Trust sold out of Ionis Pharmaceuticals (IONS) in Q1 2020, closing a stake of 4,187 shares — an estimated $253K sold.

Raymond James Trust first reported a position in IONS in Q1 2014 and held it in 19 quarters. The position peaked at $365K in Q1 2019. 362 funds tracked by Wall St. Rank hold IONS as of Q1 2020.

  • Raymond James Trust reported no remaining Ionis Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Raymond James Trust sold 4,187 Ionis Pharmaceuticals shares in Q1 2020, an estimated $253K.
  • Raymond James Trust first reported a position in Ionis Pharmaceuticals in Q1 2014 and held it in 19 quarters.
  • Raymond James Trust's Ionis Pharmaceuticals position peaked at $365K in Q1 2019.
  • 362 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2020.

Based on Raymond James Trust's 13F filing for Q1 2020, filed 17 Apr 2020.